D5.3 Deep Learning Master model and Radiomic Signatures

Mar 12, 2024 | Deliverables

Deliverable 5.3, led by partner FCHAMPALIMAUD, contains the work performed by the ProCAncer-I
consortium on master models using radiomics and deep learning techniques. ’Master models’ — models
which can act as a foundation for other models — were developed for radiomics for all relevant use cases
(UC2, UC3, UC5, UC6, UC7a, UC7b and UC8) through the development of consistent and robust pipelines,
while deep learning was used only for UC1, UC2 and UC5 due to its more demanding data requirements.
Radiomics master models were developed by three partners (FCHAMPALIMAUD, FORTH and CNR), while
deep learning master models were developed and investigated by six different partners (FCHAMPALIMAUD,
CNR, FORTH, ADVANTIS, FPO, QUIBIM). Through this approach, several aspects of deep learning models
were investigated and consistent approaches and trends were identified. We finally note that the concept of
a ’master model’ is similar to that of a foundation model; in that light, this deliverable reflects that insight.
We describe the work in terms of foundation models and provide an overview of all experiments performed
to arrive at foundation models.

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Twitter feed is not available at the moment.

Stay in touch!